Davoceticept
Product Specifications
UNSPSC Description
Davoceticept (ALPN-202; CD80 vIgD-Fc) is a monoclonal antibody targeting CTLA-4. Davoceticept consists of the (1-107) fragment of CD80 linked to IGHG1 Fc via a peptidyl linker. The expression system of Davoceticept is usually CHO (Chinese Hamster Ovary) cells[1].
Target Antigen
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/davoceticept.html
Solubility
10 mM in DMSO
Smiles
[Davoceticept]
References & Citations
[1]Davoceticept. IMGT.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99844/Davoceticept-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99844/
Clinical Information
Phase 1
CAS Number
2307144-64-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MR202781L3V 200 µL
4932438H23Rik (NM_001163695) Mouse Tagged ORF Clone Lentiviral Particle
Ask
View Details